BIO-key International, Inc.
BKYI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | 0.00 | -0.00 | 0.05 |
| FCF Yield | -44.26% | -225.75% | -133.15% | -52.38% |
| EV / EBITDA | -2.24 | -0.20 | -0.47 | -2.15 |
| Quality | ||||
| ROIC | -69.44% | -587.06% | -106.14% | -30.65% |
| Gross Margin | 81.39% | 18.46% | 65.25% | 67.29% |
| Cash Conversion Ratio | 0.68 | 0.45 | 0.52 | 1.77 |
| Growth | ||||
| Revenue 3-Year CAGR | -0.43% | 14.88% | 35.26% | 31.14% |
| Free Cash Flow Growth | 22.86% | 39.88% | 30.04% | -80.93% |
| Safety | ||||
| Net Debt / EBITDA | -0.38 | 0.02 | -0.05 | 1.65 |
| Interest Coverage | -13.38 | -40.44 | -948.54 | -274.55 |
| Efficiency | ||||
| Inventory Turnover | 3.41 | 14.19 | 0.42 | 0.34 |
| Cash Conversion Cycle | -82.78 | 10.99 | 748.57 | 1,063.28 |